You just read:

AllianceRx Walgreens Prime study demonstrates increased adherence and improvement in symptoms for psoriasis patients switching to interleukin-17 inhibitors

News provided by

AllianceRx Walgreens Prime

Sep 11, 2019, 14:19 ET